Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
2.
Rev Port Cardiol ; 42(12): 1017-1024, 2023 12.
Article in English, Portuguese | MEDLINE | ID: mdl-36758747

ABSTRACT

Global warming is a result of the increased emission of greenhouse gases. The consequences of this climate change threaten society, biodiversity, food and resource availability. The consequences include an increased risk of cardiovascular (CV) disease and cardiovascular mortality. In this position paper, we summarize the data from the main studies that assess the risks of a temperature increase or heat waves in CV events (CV mortality, myocardial infarction, heart failure, stroke, and CV hospitalizations), as well as the data concerning air pollution as an enhancer of temperature-related CV risks. The data currently support global warming/heat waves (extreme temperatures) as cardiovascular threats. Achieving neutrality in emissions to prevent global warming is essential and it is likely to have an effect in the global health, including the cardiovascular health. Simultaneously, urgent steps are required to adapt the society and individuals to this new climatic context that is potentially harmful for cardiovascular health. Multidisciplinary teams should plan and intervene healthcare related to temperature changes and heat waves and advocate for a change in environmental health policy.


Subject(s)
Cardiology , Cardiovascular Diseases , Extreme Heat , Global Warming , Humans , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , Portugal , Extreme Heat/adverse effects
3.
Rev Port Cardiol ; 41(8): 709-717, 2022 Aug.
Article in English, Portuguese | MEDLINE | ID: mdl-36073271

ABSTRACT

Air pollution is one of the main environmental risk factors for health and is linked to cardiovascular diseases, which are the leading cause of mortality worldwide. In this position paper, we discuss the main air pollutants and how they can promote the development of cardiovascular disease or cardiovascular events. We also summarise the main evidence supporting the association between air pollution and cardiovascular events, such as coronary events (acute coronary syndromes/myocardial infarction; chronic coronary syndromes), stroke, heart failure and mortality. Some recommendations are made based on these data and the European Society of Cardiology guidelines on cardiovascular disease prevention, acknowledging that it is important to increase awareness and literacy on this topic in Portugal.

5.
Rev Port Cardiol ; 35(5): 305.e1-7, 2016 May.
Article in English, Portuguese | MEDLINE | ID: mdl-27118142

ABSTRACT

The authors present a case of systemic amyloidosis with cardiac involvement. We discuss the need for a high level of suspicion to establish a diagnosis, diagnostic techniques and treatment options. Our patient was a 78-year-old man with chronic renal disease and atrial fibrillation admitted with acute decompensated heart failure of unknown cause. The transthoracic echocardiogram revealed severely impaired left ventricular function with phenotypic overlap between hypertrophic and restrictive cardiomyopathy. After an extensive diagnostic workup, which included an abdominal fat pad biopsy, the final diagnosis was amyloidosis.


Subject(s)
Amyloidosis/diagnosis , Cardiomyopathies/diagnosis , Aged , Amyloidosis/complications , Biopsy , Cardiomyopathies/complications , Echocardiography , Heart Failure/etiology , Humans , Male
6.
Rev Port Cardiol ; 33(7-8): 471.e1-6, 2014.
Article in English, Portuguese | MEDLINE | ID: mdl-25108561

ABSTRACT

The authors report the case of a 53-year-old man, with a long-standing history of mild mitral stenosis, admitted for worsening fatigue. Transthoracic echocardiography (limited by poor image quality) showed mitral annular calcification, leaflets that were difficult to visualize and an estimated mitral valve area of 1.8 cm(2) by the pressure half-time method. However, elevated mean transmitral and right ventricle/right atrium gradients were identified (39 and 117 mmHg, respectively). This puzzling discrepancy in the echocardiographic findings prompted investigation by transesophageal echocardiography, which revealed an echogenic structure adjacent to the mitral annulus, causing severe obstruction (effective orifice area 0.7 cm(2)). The suspicion of supravalvular mitral ring was confirmed during surgery. Following ring resection and mitral valve replacement there was significant improvement in the patient's clinical condition and normalization of the left atrium/left ventricle gradient. Supravalvular mitral ring is an unusual cause of congenital mitral stenosis, characterized by an abnormal ridge of connective tissue on the atrial side of the mitral valve, which often obstructs mitral valve inflow. Few cases have been reported, most of them in children with concomitant congenital abnormalities. Diagnosis of a supravalvular mitral ring is challenging, since it is very difficult to visualize in most diagnostic tests. It was the combination of clinical and various echocardiographic findings that led us to suspect this very rare condition, enabling appropriate treatment, with excellent long-term results.


Subject(s)
Mitral Valve Stenosis/diagnosis , Mitral Valve Stenosis/etiology , Mitral Valve/abnormalities , Diagnostic Errors , Humans , Male , Middle Aged , Mitral Valve/surgery
8.
Rev Port Cardiol ; 31(6): 425-32, 2012 Jun.
Article in Portuguese | MEDLINE | ID: mdl-22579836

ABSTRACT

Hypertension complicates 6-8% of pregnancies and includes the following four conditions: hypertension preceding pregnancy or documented before the 20th week of gestation; pre-eclampsia (PE)/eclampsia; chronic hypertension with superimposed pre-eclampsia; and gestational hypertension. The latter is defined as a significant rise in blood pressure after the 20th week of pregnancy in previously normotensive women, to over 140/90 mmHg. When blood pressure remains above 160/110 mmHg, it is considered severe. PE is defined as the presence of proteinuria (> or = 300 mg/24 h) in pregnant women with hypertension. The hypertensive syndromes of pregnancy are among the leading causes of maternal and fetal morbidity and mortality and anti-hypertensive treatment is part of the therapeutic arsenal used to prevent serious complications. Although the role of utero-placental insufficiency due to deficient migration of trophoblasts to the spiral arteries is universally accepted, the pathophysiology of PE remains largely unknown and is the subject of debate. No effective ways of predicting or preventing PE have been found, which highlights the need for further research in this field. This review aims primarily to evaluate recent advances in our understanding of the pathophysiology of gestational hypertension and especially PE, and new ways of predicting PE. Additionally, we present a brief review on the diagnosis, prevention and treatment of PE.


Subject(s)
Hypertension, Pregnancy-Induced , Female , Humans , Hypertension, Pregnancy-Induced/classification , Hypertension, Pregnancy-Induced/diagnosis , Hypertension, Pregnancy-Induced/physiopathology , Hypertension, Pregnancy-Induced/therapy , Pregnancy , Risk Assessment
9.
Arq. bras. cardiol ; 95(6): 144-147, dez. 2010. ilus
Article in Portuguese | LILACS | ID: lil-572193

ABSTRACT

O ganglioneuroma é um tumor do sistema nervoso simpático, podendo estar associado à hipersecreção de substâncias vasoativas responsáveis por sintomas e sinais variados, como a hipertensão arterial. Os autores apresentam um caso de ganglioneuroma e uma revisão da literatura, focando os aspectos mais importantes do diagnóstico e da terapêutica. A paciente apresentava crises hipertensivas sintomáticas recorrentes, tendo realizado estudo imaginológico que detectou uma imagem nodular na adrenal direita. Sendo os tumores neuroblásticos indistinguíveis radiologicamente, procedeu-se à excisão, confirmando-se o diagnóstico pela análise anatomopatológica. Este caso demonstra a variabilidade clínica dos ganglioneuromas, a utilidade da imaginologia e a importância do estudo histológico.


The ganglioneuroma is a tumor of the sympathetic nervous system and may be associated with hypersecretion of vasoactive substances responsible for various symptoms and signs such as hypertension. The authors report a case of ganglioneuroma and a literature review, focusing on the most important aspects of diagnosis and therapy. The patient had recurrent symptomatic hypertensive crises, having performed an imaging study that found a nodule in the right adrenal gland. As neuroblastic tumors are radiologically undistinguishable, the patient underwent excision, confirming the diagnosis by pathology analysis. This case demonstrates the clinical variability of ganglioneuroma, the usefulness of imaging and the importance of histological study.


El ganglioneuroma es un tumor del sistema nervioso simpático, y puede estar asociado con la hipersecreción de sustancias vasoactivas responsables de diversos síntomas y signos, como la hipertensión arterial. Los autores presentan un caso de ganglioneuroma y una revisión de la literatura, centrándose en los aspectos más importantes del diagnóstico y la terapéutica. El paciente tenía crisis hipertensivas sintomáticas recurrentes, e hizo un estudio imaginológico que detectó una imagen nodular en la glándula adrenal derecha. Al ser los tumores neuroblásticos radiológicamente indistinguibles, se procedió a la extirpación, lo que confirma el diagnóstico mediante el análisis anatomopatológico. Este caso demuestra la variabilidad clínica de ganglioneuroma, la utilidad de la imagiologia y la importancia del estudio histológico.


Subject(s)
Aged , Female , Humans , Adrenal Gland Neoplasms/complications , Ganglioneuroma/complications , Hypertension/etiology
10.
Arq Bras Cardiol ; 94(3): e34-6, e94-6, 2010 Mar.
Article in English, Portuguese | MEDLINE | ID: mdl-20730251

ABSTRACT

A 73-year-old woman was admitted to the emergency room with predominantly right-sided heart failure and anemia. Following clinical and imagiological evaluation, a diagnosis of pulmonary hypertension (PH) associated with Hereditary Hemorrhagic Telangiectasia (HHT) was confirmed. The initial response to bosentan plus sildenafil was good, including improvement in functional class and reduction of edema, allowing her to be discharged. Unfortunately, the patient died, due to her underlying condition, before the effects of the combination treatment could be fully assessed. PH should be considered in patients with HTT and screening for pulmonary hypertension should be performed in these patients and their relatives.


Subject(s)
Hypertension, Pulmonary/complications , Telangiectasia, Hereditary Hemorrhagic/etiology , Aged , Antihypertensive Agents/therapeutic use , Bosentan , Fatal Outcome , Female , Humans , Hypertension, Pulmonary/therapy , Sulfonamides/therapeutic use , Telangiectasia, Hereditary Hemorrhagic/therapy
11.
Arq. bras. cardiol ; 94(3): e94-e96, mar. 2010. ilus
Article in Portuguese | LILACS | ID: lil-545836

ABSTRACT

Uma mulher de 73 anos foi admitida ao Pronto-Socorro com insuficiência cardíaca predominantemente direita e anemia. Após avaliação clínica e imagenológica, um diagnóstico de hipertensão pulmonar (HP) associado com telangiectasia hemorrágica hereditária (THH) foi confirmado. A resposta inicial à terapia com bosentan mais sildenafil foi boa, incluindo melhora na Classe Funcional e redução do edema, permitindo que ela recebesse alta hospitalar. Infelizmente, a paciente faleceu devido à sua condição básica, antes que o efeito do tratamento combinado pudesse ser completamente avaliado. A HP deve ser considerada em pacientes com THH e o screening para HP deve ser conduzido nesses pacientes e em seus familiares.


A 73-year-old woman was admitted to the emergency room with predominantly right-sided heart failure and anemia. Following clinical and imagiological evaluation, a diagnosis of pulmonary hypertension (PH) associated with Hereditary Hemorrhagic Telangiectasia (HHT) was confirmed. The initial response to bosentan plus sildenafil was good, including improvement in functional class and reduction of edema, allowing her to be discharged. Unfortunately, the patient died, due to her underlying condition, before the effects of the combination treatment could be fully assessed. PH should be considered in patients with HTT and screening for pulmonary hypertension should be performed in these patients and their relatives.


Subject(s)
Aged , Female , Humans , Hypertension, Pulmonary/complications , Telangiectasia, Hereditary Hemorrhagic/etiology , Antihypertensive Agents/therapeutic use , Fatal Outcome , Hypertension, Pulmonary/therapy , Sulfonamides/therapeutic use , Telangiectasia, Hereditary Hemorrhagic/therapy
12.
Arq Bras Cardiol ; 95(6): e144-7, 2010 Dec.
Article in English, Portuguese, Spanish | MEDLINE | ID: mdl-21271185

ABSTRACT

The ganglioneuroma is a tumor of the sympathetic nervous system and may be associated with hypersecretion of vasoactive substances responsible for various symptoms and signs such as hypertension. The authors report a case of ganglioneuroma and a literature review, focusing on the most important aspects of diagnosis and therapy. The patient had recurrent symptomatic hypertensive crises, having performed an imaging study that found a nodule in the right adrenal gland. As neuroblastic tumors are radiologically undistinguishable, the patient underwent excision, confirming the diagnosis by pathology analysis. This case demonstrates the clinical variability of ganglioneuroma, the usefulness of imaging and the importance of histological study.


Subject(s)
Adrenal Gland Neoplasms/complications , Ganglioneuroma/complications , Hypertension/etiology , Aged , Female , Humans
13.
Rev Port Cardiol ; 27(5): 707-22, 2008 May.
Article in English, Portuguese | MEDLINE | ID: mdl-18717218

ABSTRACT

The role of viruses in cardiovascular disease has been increasingly recognized in recent years. They are now thought to be the main agent in acute myocarditis and inflammatory cardiomyopathy in the western world. We describe new perspectives on the part viral agents play in heart disease, from molecular mechanisms to recently available diagnostic and therapeutic options. We present a case of post-viral dilated cardiomyopathy in a 29-year-old woman in order to illustrate the severe damage that a viral infection can cause and the different therapeutic options that may be available in the near future.


Subject(s)
Myocarditis/virology , Virus Diseases , Adult , Decision Trees , Female , Humans , Myocarditis/complications , Myocarditis/diagnosis , Myocarditis/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...